Fresenius SE & Co. KGaA: Pierluigi Antonelli, Kauf
EQS-DD: Fresenius SE & Co. KGaA (deutsch). KGaA: Pierluigi ...
Fresenius SE & Co. KGaA: Sara Hennicken, buy
Fresenius SE & Co. KGaA: Sara Hennicken, Kauf
EQS-DD: Fresenius SE & Co. KGaA (deutsch). KGaA: Sara Hennicken ...
Fresenius SE & Co. KGaA: Robert Möller, buy
Fresenius SE & Co. KGaA: Robert Möller, Kauf
EQS-DD: Fresenius SE & Co. KGaA (deutsch). KGaA: Robert ...
Dax dreht ins Plus - Rheinmetall vorn
Fresenius posted 7% organic growth and 12% EPS rise in FY2025 ...
EQS-CMS: Fresenius Medical Care AG : Veröffentlichung einer ...
EQS-CMS: Fresenius Medical Care AG : Release of a capital ...
Fresenius shares break key technical levels as political ...
Die Fresenius-Aktie notiert unter wichtigen Durchschnittslinien ...
Fresenius targets 7% organic sales growth and an 11.5% EBIT ...
Der Dialysekonzern investierte allein in einer Märzwoche ...
EQS-CMS: Fresenius Medical Care AG : Veröffentlichung einer ...
EQS-CMS: Fresenius Medical Care AG : Release of a capital ...
Fresenius extends CEO Michael Sen's contract early to 2031 ...
Fresenius CFO Sara Hennicken buys shares amid stock decline ...
Finanzvorständin Sara Hennicken kauft Fresenius-Aktien ...
IV Equipment Market worth $23.92 billion by 2031 | MarketsandMarkets™ ...
Fresenius SE & Co. KGaA: Sara Hennicken, buy
Fresenius SE & Co. KGaA: Sara Hennicken, Kauf
EQS-DD: Fresenius SE & Co. KGaA (deutsch). KGaA: Sara Hennicken ...
Die Fresenius-Aktie verliert deutlich an Boden und durchbricht ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
IV Equipment Market worth $23.92 billion by 2031 | MarketsandMarkets™ ...
IV Equipment Market worth $23.92 billion by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
EQS-HV: Knorr-Bremse Aktiengesellschaft: Bekanntmachung ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Fresenius Medical Care AG: Release according to Article ...
Secarna Pharmaceuticals establishes Advisory Board with ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Fresenius CEO warns Europe's reliance on Chinese pharma ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
IV Equipment Market worth $23.92 billion by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
IV Equipment Market worth $23.92 billion by 2031 | MarketsandMarkets™ ...
IV Equipment Market worth $23.92 billion by 2031 | MarketsandMarkets™ ...
IV Equipment Market worth $23.92 billion by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
IV Equipment Market worth $23.92 billion by 2031 | MarketsandMarkets™ ...
Fresenius Medical Care AG: Helen Pring Giza Acquisition ...
Fresenius Medical Care AG: Helen Pring Giza Kauf von Aktien ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
IV Equipment Market worth $23.92 billion by 2031 | MarketsandMarkets™ ...
IV Equipment Market worth $23.92 billion by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™ ...
IV Equipment Market worth $23.92 billion by 2031 | MarketsandMarkets™ ...
Fresenius Medical Care steht vor einem entscheidenden Quartalsbericht ...
Sara Hennicken s insider purchase signals leadership confidence amid Fresenius ...
Das neue Krankenhausreformanpassungsgesetz treibt die Nachfrage ...
Fresenius SE & Co. KGaA: Sara Hennicken, buy
Fresenius SE & Co. KGaA: Sara Hennicken, Kauf
EQS-DD: Fresenius SE & Co. KGaA (deutsch). KGaA: Sara Hennicken ...
EQS-CMS: Fresenius Medical Care AG : Veröffentlichung einer ...
EQS-CMS: Fresenius Medical Care AG : Release of a capital ...
Fitnessstudios entwickeln sich zu Partnern des Gesundheitssystems ...
JPMorgan erhöht das Kursziel für Fresenius während die ...
Kontaktlinsen Frauengesundheit KI im OP: CooperCompanies ...
JPMorgan upgrades Fresenius price target to €56.60 citing ...
Fresenius SE & Co. KGaA hat nach der Abspaltung von Fresenius ...
Eine Göttinger Studie zeigt dass die bakterielle Zusammensetzung ...
Steris plc gilt als leiser Riese in der Medizintechnik – ...
ANALYSE-FLASH: JPMorgan hebt Ziel fĂĽr Fresenius SE auf ...
Die Primary Health Aktie mit der ISIN GB00BYRJ5J14 profitiert ...
Die ResMed Inc. Aktie (US7611521078) profitiert von einem ...
Die Fresenius Medical Care Aktie (ISIN: DE0005785802) steht ...
Fresenius sortiert den Konzern nach Jahren des Umbaus neu ...
Die Stryker Corp. Aktie profitiert von einem robusten Medtech-Zyklus ...
Die Fresenius Medical Care Aktie (ISIN: DE0005785802) steht ...
Fresenius arbeitet weiter an Margenverbesserung Schuldenabbau ...
Die DaVita Inc. Aktie zeigt sich nach jĂĽngsten Kursschwankungen ...
Die EssilorLuxottica Aktie profitiert von ihrer starken ...
Die Fresenius Medical Care Aktie (ISIN: DE0005785802) bleibt ...
Die Fresenius Aktie (ISIN: DE0005785604) bleibt fĂĽr DACH-Anleger ...
BlackRock's 5.42% voting rights stake in Fresenius Medical ...
Fresenius Medical Care AG: Release according to Article ...
Die Fresenius Medical Care Aktie (ISIN: DE0005785802) steht ...
Fresenius arbeitet weiter an Schuldenabbau Portfoliofokus ...
Die Universal Health Services Aktie steht nach jĂĽngsten ...
Die Drägerwerk Aktie (DE0005550636) bleibt im Gesundheits- ...
Die Hologic Aktie profitiert von soliden Fundamentaldaten ...
Fresenius arbeitet weiter am Umbau vom verschachtelten Gesundheitskonglomerat ...
Die Hengrui Medicine Aktie steht im Spannungsfeld zwischen ...